These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30930207)

  • 1. High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma.
    Meng X; Chao B; Vijay V; Silver H; Margolin EJ; Balar A; Taneja SS; Shah O; Bjurlin MA; Anderson CB; Huang WC
    Urology; 2019 Jul; 129():146-152. PubMed ID: 30930207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma.
    Huang YC; Chen MF; Shi CS; Shindel AW; Huang CE; Pang ST; Chuang CK; Chen CS; Chang YH; Lin WY; Ho DR; Chin CC; Kuo YH; Wu CF
    J Urol; 2015 Aug; 194(2):323-9. PubMed ID: 25796114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.
    Zennami K; Sumitomo M; Takahara K; Nukaya T; Takenaka M; Fukaya K; Ichino M; Fukami N; Sasaki H; Kusaka M; Shiroki R
    BJU Int; 2021 Mar; 127(3):332-339. PubMed ID: 32896105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Outcomes in Neoadjuvant Chemotherapy for High-grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis.
    Khan AI; Taylor BL; Al Hussein Al Awamlh B; Posada Calderon L; Fainberg J; Elahjji R; Shoag J; Scherr DS
    Urology; 2020 Dec; 146():158-167. PubMed ID: 32896584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
    Singla N; Christie A; Freifeld Y; Ghandour RA; Woldu SL; Clinton TN; Petros FG; Robyak H; Yeh HC; Fang D; Enikeev D; Bagrodia A; Sagalowsky AI; Lotan Y; Raman JD; Matin SF; Margulis V
    Urol Oncol; 2020 Dec; 38(12):933.e7-933.e12. PubMed ID: 32430254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcome.
    Yafi FA; Tanguay S; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Lacombe L; Chin J; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Kassouf W
    Urol Oncol; 2014 Jan; 32(1):31.e17-24. PubMed ID: 23428535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma.
    Shigeta K; Kikuchi E; Abe T; Hagiwara M; Ogihara K; Anno T; Umeda K; Baba Y; Sanjo T; Shojo K; Mikami S; Mizuno R; Oya M
    Eur Urol Oncol; 2020 Dec; 3(6):756-763. PubMed ID: 31395480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Adjuvant Chemotherapy on Locally Advanced Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis.
    Kim DK; Kim JW; Jung HD; Ahn HK; Lee JY; Cho KS
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1193-e1202. PubMed ID: 31543442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
    Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
    Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis.
    Quhal F; Mori K; Sari Motlagh R; Laukhtina E; Pradere B; Rouprêt M; Necchi A; Moschini M; Shariat SF
    Int J Clin Oncol; 2020 Jun; 25(6):1037-1054. PubMed ID: 32206939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis.
    Sevillano E; Werner L; Bossé D; Lalani AA; Wankowicz SAM; de Velasco G; Farina M; Lundgren K; Choueiri TK; González Del Alba A; Bellmunt J
    Clin Genitourin Cancer; 2017 Dec; 15(6):e1089-e1094. PubMed ID: 28864222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis.
    Kim DK; Lee JY; Kim JW; Hah YS; Cho KS
    Crit Rev Oncol Hematol; 2019 Mar; 135():59-65. PubMed ID: 30819447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
    J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review.
    Aziz A; Dobruch J; Hendricksen K; Kluth LA; Necchi A; Noon A; Rink M; Roghmann F; Seiler R; Gontero P; Kassouf W; Shariat SF; Xylinas E;
    World J Urol; 2017 Sep; 35(9):1401-1407. PubMed ID: 28074261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery.
    Almassi N; Gao T; Lee B; Stein RJ; Haber GP; Ornstein MC; Rini BI; Gilligan TD; Garcia JA; Stephenson AJ; Grivas P
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1237-e1242. PubMed ID: 30217764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
    Porten S; Siefker-Radtke AO; Xiao L; Margulis V; Kamat AM; Wood CG; Jonasch E; Dinney CP; Matin SF
    Cancer; 2014 Jun; 120(12):1794-9. PubMed ID: 24633966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy.
    Xylinas E; Rink M; Margulis V; Clozel T; Lee RK; Comploj E; Novara G; Raman JD; Lotan Y; Weizer A; Roupret M; Pycha A; Scherr DS; Seitz C; Ficarra V; Trinh QD; Karakiewicz PI; Montorsi F; Zerbib M; Shariat SF;
    BJU Int; 2013 Aug; 112(4):453-61. PubMed ID: 23464979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected High-Risk Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy for Adjuvant Chemotherapy: A Multi-Institutional Retrospective Study.
    Ikeda M; Matsumoto K; Hirayama T; Koguchi D; Murakami Y; Matsuda D; Okuno N; Utsunomiya T; Taoka Y; Irie A; Iwamura M
    Clin Genitourin Cancer; 2018 Jun; 16(3):e669-e675. PubMed ID: 29239844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [OUTCOMES AFTER SURGICAL TREATMENT OF UPPER TRACT UROTHELIAL CARCINOMA].
    Moritake J; Miki J; Tsuzuki S; Hata K; Shimomura T; Kimura T; Furuta A; Furuta N; Egawa S
    Nihon Hinyokika Gakkai Zasshi; 2016; 107(2):79-86. PubMed ID: 28442674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.